Skip to main content
. 2019 Dec 16;11(12):2029. doi: 10.3390/cancers11122029
PCa prostate cancer
TMA tissue microarray
OS overall survival
DSS disease-free survival
RFS relapse-free survival
IHC immunohistochemistry
pT pathological tumor stage
pN pathological lymph node stage
GS Gleason score
IRS immunoreactive score
n.s. nonsignificant
n.d. not determined